Brandenburg Endocarditis Registry
Recruiting
- Conditions
- I38I33Endocarditis, valve unspecifiedAcute and subacute endocarditis
- Registration Number
- DRKS00023423
- Lead Sponsor
- Abteilung für Herz- und Gefäßchirurgie, Medizinische Hochschule Brandenburg, Immanuel Klinikum Bernau
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Confirmed Endocarditis Diagnosis
Presence of written consent
Exclusion Criteria
Rejection of the diagnosis or therapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In-Hospital mortality.<br>The perioperative mortality of endocarditis patients during hospitalization (From hospital admission to hospital discharge) is recorded.
- Secondary Outcome Measures
Name Time Method Combined cardiovascular event,<br>Incidence and prevalence,<br>complications,<br>Germination frequency and behavior (resistance),<br>Prophylaxis,<br>Diagnostic time interval,<br>Hospitalization time,<br>Re-hospitalization rate,<br>Recurrence rate,<br>Reoperation rate,<br>1 year survival
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie acute and subacute endocarditis in the BER registry?
How does the BER registry compare standard-of-care treatments for I38 and I33 endocarditis?
What biomarkers are used for patient selection in the Brandenburg Endocarditis Registry?
What adverse events are associated with valve unspecified endocarditis treatments in BER?
Are there novel compounds or combination therapies being evaluated for endocarditis in BER?